Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
JDP Therapeutics
JDP Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Quzyttir
Cetirizine
2019-10-04
2030-2032
Allergic rhinitis perennial
,
Urticaria
,
Sinusitis
,
Asthma
,
Common cold
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Cetirizine
healthy volunteers/patients
Terfenadine
cold urticaria
,
renal cell carcinoma
,
carcinoma
,
kidney neoplasms
,
allergic rhinitis
,
rhinitis
,
blood pressure
,
cardiac arrhythmias
,
heart rate
,
breast neoplasms
,
triple negative breast neoplasms
,
chronic inducible urticaria
,
angioedema
,
respiratory tract infections
,
nasal obstruction
,
rhinorrhea
,
sneezing
,
urticaria
,
chronic urticaria
,
conjunctivitis
,
allergic conjunctivitis
Sominex
neoplasms
,
circulating neoplastic cells
,
immune system diseases
,
leukemia
,
lymphoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
renal insufficiency
,
hematologic diseases
,
blood protein disorders
,
neoplasms by histologic type
,
paraproteinemias
,
multiple myeloma
,
plasma cell neoplasms
,
smoldering multiple myeloma
,
prostatic neoplasms
,
fabry disease
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use